LAM-002A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LAM-002A, covering 2023-08-08 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis [Phase 2]